Archives: Agenda

Brocacef专场

• Moving beyond proof-of-concept to enterprise-wide AI adoption
• Demonstrating measurable impact across study design, recruitment, and trial execution
• Overcoming data, integration, and governance challenges to scale successfully
• Building the foundations for sustainable, AI-enabled clinical development

• 从概念验证迈向企业级 AI 应用。
• 在研究设计、招募和试验执行中展示可衡量影响。
• 克服数据、集成和治理挑战，实现成功规模化。
• 为可持续的 AI 赋能临床开发奠定基础。

• Embedding resilience into supply chain strategy, operations, and quality systems
• Leveraging digital technologies and data visibility to anticipate and mitigate disruptions
• Strengthening supplier networks and risk management frameworks for long-term continuity
• Balancing agility, compliance, and efficiency in an evolving global landscape

• 供应链战略、运营和质量体系的风险管控。
• 利用数字技术与数据可视化提前识别并缓解中断风险。
• 强化供应商网络与风险管理框架，保障弹性供应能力。
• 在不断演变的全球格局中平衡便利性、合规性和效率。

• Understanding country-specific site application and approval requirements
• Reducing start-up timelines through effective planning and local partnerships
• Common challenges and pitfalls when activating sites across multiple regions
• Best practices for successful collaboration with investigators, sites, and regulators

• 了解各国特定的中心申请与审批要求。
• 通过有效规划和本地合作伙伴关系缩短启动时间。
• 跨多个区域启动中心时常见的挑战和陷阱。
• 与研究者、中心和监管方成功协作的最佳实践

Moderator:

Julia Leng Multitude Therapeutics